Brief: Promore Pharma Q3 Operating Loss Widens To SEK 7.4 Million
Nov 23 (Reuters) - Promore Pharma AB PROMO.ST :
* Q3 OPERATING LOSS SEK 7.4 MILLION VERSUS LOSS SEK 4.4
MILLION
YEAR AGO
* Q3 NET SALES AMOUNTED TO 1.0 (0) MSEK
Source text for Eikon: ID:nWkr5fP1H9
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality